Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Conversion Efficiency
Chengdu Easton Biopharmaceuticals Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥61.35 Million ≈ $8.98 Million USD) by net assets (CN¥2.87 Billion ≈ $419.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Cash flow conversion efficiency of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. This chart illustrates how Chengdu Easton Biopharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688513 live share price for real-time trading data and today's change.
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Conversion Ratio Explained
Chengdu Easton Biopharmaceuticals Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Chengdu Easton Biopharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chengdu Easton Biopharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Also see 688513 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Suzhou Douson Drilling & Production Equipment Co Ltd
SHG:603800
|
-0.049x |
|
Lindsay Corporation
NYSE:LNN
|
0.013x |
|
Virtus Investment Partners, Inc.
NASDAQ:VRTS
|
0.106x |
|
MAC Copper Ltd
AU:MAC
|
0.243x |
|
Beijing Urban Rural Commercial Group Co Ltd
SHG:600861
|
0.059x |
|
Zimplats Holdings Ltd
AU:ZIM
|
-0.001x |
|
HYDROGRAPH CLEAN POWER
F:M98
|
-0.100x |
|
Zoomlion Heavy Industry Science and Technology Co. Ltd
F:8CZ
|
0.019x |
Annual Cash Flow Conversion Efficiency for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. Review Chengdu Easton Biopharmaceuticals Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.66 Billion ≈ $975.13 Million |
CN¥264.94 Million ≈ $38.77 Million |
0.040x | -59.25% |
| 2024-12-31 | CN¥2.70 Billion ≈ $394.79 Million |
CN¥263.24 Million ≈ $38.52 Million |
0.098x | -7.71% |
| 2023-12-31 | CN¥2.60 Billion ≈ $380.96 Million |
CN¥275.25 Million ≈ $40.28 Million |
0.106x | +70.09% |
| 2022-12-31 | CN¥2.44 Billion ≈ $357.70 Million |
CN¥151.94 Million ≈ $22.23 Million |
0.062x | -3.49% |
| 2021-12-31 | CN¥2.29 Billion ≈ $335.34 Million |
CN¥147.60 Million ≈ $21.60 Million |
0.064x | -13.79% |
| 2020-12-31 | CN¥2.10 Billion ≈ $306.60 Million |
CN¥156.52 Million ≈ $22.90 Million |
0.075x | -63.26% |
| 2019-12-31 | CN¥697.44 Million ≈ $102.06 Million |
CN¥141.83 Million ≈ $20.75 Million |
0.203x | -29.02% |
| 2018-12-31 | CN¥582.19 Million ≈ $85.19 Million |
CN¥166.79 Million ≈ $24.41 Million |
0.286x | +48.85% |
| 2017-12-31 | CN¥445.28 Million ≈ $65.16 Million |
CN¥85.70 Million ≈ $12.54 Million |
0.192x | -29.27% |
| 2016-12-31 | CN¥389.79 Million ≈ $57.04 Million |
CN¥106.06 Million ≈ $15.52 Million |
0.272x | +44.32% |
| 2015-12-31 | CN¥268.21 Million ≈ $39.25 Million |
CN¥50.57 Million ≈ $7.40 Million |
0.189x | -17.97% |
| 2014-12-31 | CN¥203.25 Million ≈ $29.74 Million |
CN¥46.71 Million ≈ $6.84 Million |
0.230x | +37.82% |
| 2013-12-31 | CN¥168.62 Million ≈ $24.67 Million |
CN¥28.12 Million ≈ $4.11 Million |
0.167x | -- |
About Chengdu Easton Biopharmaceuticals Co Ltd
Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients; finished dosage forms, including capsules, tablets, and injections; pharmaceutical intermediates; biological drugs; and generic drugs. I… Read more